Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 11

    US shows interest in potential coronavirus vaccine developer CureVac, Germany stakes claim

    US shows interest in potential coronavirus vaccine developer CureVac, Germany stakes claim

    Medical Dialogues Bureau17 March 2020 1:00 PM IST
    Berlin: Germany staked its claim Sunday to ongoing work into a vaccine against the coronavirus, after media reports claimed US President Donald Trump...
    Lasa , ICT explore Favipiravir therapy for Coronavirus, to apply to DCGI

    Lasa , ICT explore Favipiravir therapy for Coronavirus, to apply to DCGI

    Medical Dialogues Bureau17 March 2020 12:14 PM IST
    Mumbai: Lasa Supergenerics Ltd In collaboration with Institute of Chemical Technology (ICT) recently announced commencement for Development of...
    Alembic Pharma gets 4 observations from USFDA for Panelav facility

    Alembic Pharma gets 4 observations from USFDA for Panelav facility

    Medical Dialogues Bureau17 March 2020 10:57 AM IST
    Gujarat: Alembic Pharmaceuticals has announced that the US Food and Drug Administration (USFDA) has conducted an inspection at Alembic...
    Coronavirus Outbreak: OPPI assures continuity of supply of medicines

    Coronavirus Outbreak: OPPI assures continuity of supply of medicines

    Medical Dialogues Bureau17 March 2020 9:00 AM IST
    OPPI and its member companies reassure the availability of adequate supplies of medicines for those in need of them
    Dr Satish Reddy appointed as CII Southern region chairman

    Dr Satish Reddy appointed as CII Southern region chairman

    Medical Dialogues Bureau16 March 2020 2:00 PM IST
    Chennai: The Chairman of Hyderabad-based Dr Reddy''s Laboratories Ltd Satish Reddy has been elected Chairman of Confederation of Indian Industry,...
    Coronavirus: Kerala surgical shop sells face masks for Rs 2

    Coronavirus: Kerala surgical shop sells face masks for Rs 2

    Medical Dialogues Bureau16 March 2020 1:06 PM IST
    The government has declared face masks and hand sanitisers as essential commodities for the next 100 days to prevent hoarding of these items in its...
    PM Modi requested to allow  export of raw medical supplies to Israel: Report

    PM Modi requested to allow export of raw medical supplies to Israel: Report

    Medical Dialogues Bureau16 March 2020 9:30 AM IST
    Jerusalem: Israeli Prime Minister Benjamin Netanyahu requested Narendra Modi to approve and allow the export of masks and pharmaceutical raw materials...
    Biohaven Nurtec™ ODT (rimegepant) launch in US market for migraine  in adults

    Biohaven Nurtec™ ODT (rimegepant) launch in US market for migraine in adults

    Medical Dialogues Bureau16 March 2020 9:00 AM IST
    Treatment with NURTEC ODT is simple – a single dose of 75 mg provides fast pain relief, returns patients to normal function within one hour, and...
    Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test

    Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test

    Medical Dialogues Bureau15 March 2020 12:49 PM IST
    Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2...
    Accelerating Biopharmaceutical development: Dr Harsh Vardhan informs parliament about National Biopharma Mission

    Accelerating Biopharmaceutical development: Dr Harsh Vardhan informs parliament about National Biopharma Mission

    Medical Dialogues Bureau15 March 2020 11:15 AM IST
    The program is promoting entrepreneurship by supporting small and medium enterprises for indigenous product development and through establishment of...
    Alkem Laboratories receives EIR from USFDA for Baddi facility

    Alkem Laboratories receives EIR from USFDA for Baddi facility

    Medical Dialogues Bureau15 March 2020 9:15 AM IST
    New Delhi: Drug firm Alkem Laboratories on Friday said the US health regulator has issued an establishment inspection report (EIR) for its...
    Cadila Healthcare BOD approves transfer of Animal Healthcare Business to Zydus Animal Health and Investments Limited

    Cadila Healthcare BOD approves transfer of Animal Healthcare Business to Zydus Animal Health and Investments Limited

    Medical Dialogues Bureau15 March 2020 9:00 AM IST
    New Delhi: Cadila Healthcare Ltd. has recently announced that the Board of Directors at its meeting, has approved the transfer of Animal Healthcare...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok